Schistosomiasis in Senegal

Status Active, not recruiting

Clinical Trial Summary

Schistosomiasis is a flatworm transmitted from freshwater snails to humans in the tropics. In addition to this infectious disease, tropical developing countries are faced with malnutrition. We propose to alter pesticide and compost use to reduce schistosomiasis and maintain or even improve crop production.

Clinical Trial Description

We propose two types of manipulations. Bottom-up manipulations will affect snail resources, whereas top-down manipulations will affect snail predators. For the bottom-up manipulations, we will clear schistosoma infections in school children, then remove the primary habitat for snails, the submerged macrophyte Ceratophyllum demersum (with proper unmanipulated controls), compost it, apply it to crops, and then quantify reinfection rates and crop yields. The second bottom-up manipulation will be to clear schistosoma infections in school children, apply three agrochemical treatments (status quo control, shift to lower risk herbicides, or eliminate herbicides and fertilizers), and then quantify reinfection rates and crop yields. Farmers will be compensated for any loss in yields. For the top-down manipulations, every village will receive prawns that depredate snails. We will clear schistosoma infections in school children, apply three agrochemical treatments (status quo control, shift to lower risk insecticides that don't kill prawns, or eliminate insecticides), and then quantify reinfection rates and crop yields. Farmers will be compensated for any loss in yields. ;

Study Design

Related Conditions & MeSH terms

Schistosomiasis

Clinical Trial Details

NCT number	NCT03187366
Study type	Interventional
Source	University of Notre Dame
Contact
Status	Active, not recruiting
Phase	N/A
Start date	January 2, 2017
Completion date	September 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04115072` - Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study	Phase 2/Phase 3
Not yet recruiting	`NCT05999825` - Sm-p80 Schistosomiasis Challenge Study	Phase 2
Completed	`NCT00463931` - Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana	N/A
Completed	`NCT00215267` - The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	N/A
Completed	`NCT00276224` - Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia	N/A
Completed	`NCT03845140` - L-PZQ ODT in Schistosoma Infected Children	Phase 3
Completed	`NCT01512277` - Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis	Phase 1
Active, not recruiting	`NCT03910972` - Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults	Phase 1/Phase 2
Completed	`NCT05085470` - Repeated Controlled Human Schistosoma Mansoni Infection	N/A
Completed	`NCT02755324` - Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding	N/A
Recruiting	`NCT05868005` - Delivering a Multi-disease Screening Tool to Migrant Populations	N/A
Active, not recruiting	`NCT01869465` - Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Recruiting	`NCT04589390` - Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension	Phase 2
Completed	`NCT02868385` - Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)	Phase 3
Recruiting	`NCT05762393` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar	Phase 1
Not yet recruiting	`NCT06182176` - Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control	N/A
Active, not recruiting	`NCT05292391` - Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults	Phase 1
Completed	`NCT03110757` - A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults	Phase 1
Completed	`NCT01154049` - Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis	Phase 1